You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Celgene

Showing 1 - 25 of 1,034
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hematologic Tumor, Tumors Trial in Gainesville, Baltimore, Houston (CC-486)

Active, not recruiting
  • Hematologic Neoplasm
  • Neoplasms
  • Gainesville, Florida
  • +2 more
Jan 12, 2023

Psoriatic Nail, Psoriasis Vulgaris, Psoriasis Trial in Birmingham (Apremilast)

Completed
Has Results
  • Psoriatic Nail
  • +2 more
  • Birmingham, Alabama
    The Kirklin Clinic
Sep 29, 2022

MDS Over Time - Comparison of Treated vs Untreated Patients

Completed
  • Myelodysplastic Syndromes
    • Vienna, Austria
      Hanusch Krankenhaus, 3.Medizinische Abteilung
    Nov 21, 2022

    Relapsed or Refractory Multiple Myeloma Trial (Daratumumab, Pomalidomide)

    Withdrawn
    • Relapsed or Refractory Multiple Myeloma
    • (no location specified)
    Jan 26, 2023

    CD Trial in Leuven, Clichy (Colonoscopy)

    Completed
    • CD
    • Colonoscopy
    • Leuven, Belgium
    • +1 more
    Aug 2, 2022

    Melanoma Trial in Tampa (CC-122, Nivolumab)

    Completed
    Has Results
    • Melanoma
    • Tampa, Florida
      H Lee Moffitt Cancer Center and Research Institute
    Sep 27, 2022

    Langerhans Cell Histiocytosis (LCH), Histiocytoses Erdheim-chester Disease, Histiocytic Sarcoma (HS) Trial in Boston

    Active, not recruiting
    • Langerhans Cell Histiocytosis (LCH)
    • +2 more
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Aug 26, 2022

    Multiple Myeloma in Relapse, Multiple Myeloma, Refractory Trial in Poitiers (Isatuximab, Carfilzomib, Pomalidomide)

    Active, not recruiting
    • Multiple Myeloma in Relapse
    • Multiple Myeloma, Refractory
    • Poitiers, France
      CHU Poitiers
    Jan 9, 2023

    Lymphoid Leukemia, Small Lymphocytic Lymphoma, Lymphoma, Non-Hodgkin Trial in Madison (Bendamustine, Rituximab, Lenalidomide)

    Completed
    • Lymphoid Leukemia
    • +2 more
    • Madison, Wisconsin
      University of Wisconsin
    Jan 30, 2023

    Acute Myeloid Leukemia, Relapsed Cancer, Refractory Cancer Trial in Edmonton, Toronto (Enasidenib, Venetoclax)

    Active, not recruiting
    • Acute Myeloid Leukemia
    • +3 more
    • Edmonton, Alberta, Canada
    • +1 more
    Jan 31, 2023

    Leukemia, Lymphoma Trial in Houston (Rituximab, Lenalidomide)

    Active, not recruiting
    • Leukemia
    • Lymphoma
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Oct 11, 2022

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Tampa (High Dose Methylprednisolone (HDMP), Ofatumumab,

    Active, not recruiting
    Has Results
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • High Dose Methylprednisolone (HDMP)
    • +2 more
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Jan 12, 2023

    MDS Patients Using Sequential Peripheral Blood Samples

    Recruiting
    • Myelodysplastic Syndromes
      • Badalona, Barcelona, Spain
        Josep Carreras Leukaemia Research Institute
      Mar 8, 2022

      Metastatic Pancreatic Cancer, Adenocarcinoma of the Pancreas Trial in Weiden (nab-paclitaxel and gemcitabine, gemcitabine mono

      Completed
      • Metastatic Pancreatic Cancer
      • Adenocarcinoma of the Pancreas
      • nab-paclitaxel and gemcitabine
      • gemcitabine mono and nab-paclitaxel and gemcitabine
      • Weiden, Germany
        Kliniken Nordoberpfalz AG, Klinikum Weiden
      Nov 21, 2022

      Primary Myelofibrosis, Secondary Myelofibrosis Trial in Greifswald, Halle (Saale) (Fedratinib Oral Capsule [Inrebic], Nivolumab)

      Recruiting
      • Primary Myelofibrosis
      • Secondary Myelofibrosis
      • Greifswald, Germany
      • +1 more
      Jun 15, 2022

      Healthy Volunteers Trial in Daytona Beach (Iberdomide)

      Recruiting
      • Healthy Volunteers
      • Daytona Beach, Florida
        Labcorp Clinical Research Unit, Inc. - Daytona Beach
      Jun 9, 2023

      Resectable Pancreatic Cancer, Ductal Adenocarcinoma of the Pancreas Trial in Ulm (perioperative nab-paclitaxel/gemcitabine,

      Completed
      • Resectable Pancreatic Cancer
      • Ductal Adenocarcinoma of the Pancreas
      • perioperative nab-paclitaxel/gemcitabine
      • adjuvant nab-paclitaxel/gemcitabine
      • Ulm, Germany
        University of Ulm, Dept. of Internal Medicine I
      Nov 21, 2022

      Melanoma and Other Malignant Tumors of Skin, Metastatic Melanoma Trial in Houston (Azacitidine, Pembrolizumab)

      Active, not recruiting
      • Melanoma and Other Malignant Neoplasms of Skin
      • Metastatic Melanoma
      • Houston, Texas
        University of Texas MD Anderson Cancer Center
      Oct 31, 2022

      Breast Cancer Trial in Houston (Panitumumab, Nab-paclitaxel, Carboplatin)

      Completed
      Has Results
      • Breast Cancer
      • Houston, Texas
        University of Texas MD Anderson Cancer Center
      Sep 20, 2022

      Multiple Myeloma Trial in Busan (Lenalidomide, Dexamethasone)

      Recruiting
      • Multiple Myeloma
      • Busan, Western, Korea, Republic of
        Kosin University Gospel Hospital
      Mar 31, 2022

      Previously Untreated Peripheral T-cell Lymphoma Trial in Tampa, Saint Louis, New York (CC-486 Administration, CHOP

      Active, not recruiting
      Has Results
      • Previously Untreated Peripheral T-cell Lymphoma
      • CC-486 Administration
      • CHOP Administration
      • Tampa, Florida
      • +3 more
      Jan 18, 2023

      NSCLC Trial in Boston, New York (MPDL3280A, Carboplatin, Nab-paclitaxel)

      Completed
      • Carcinoma, Non-Small-Cell Lung
      • Boston, Massachusetts
      • +1 more
      Oct 12, 2022

      Study Thalamus Changes Using AI in MS

      Active, not recruiting
      • Multiple Sclerosis
        • Buffalo, New York
          University at Buffalo
        Mar 9, 2022

        Smoldering Multiple Myeloma Trial in Boston (Ixazomib, Lenalidomide, Dexamethasone)

        Active, not recruiting
        • Smoldering Multiple Myeloma
        • Boston, Massachusetts
          Dana Farber Cancer Institute
        Mar 15, 2022

        Myelodysplastic Syndrome Trial in New York (Revlimid (Lenalidomide))

        Active, not recruiting
        Has Results
        • Myelodysplastic Syndrome
        • Revlimid (Lenalidomide)
        • New York, New York
          Columbia University Medical Center
        Jan 12, 2022